Guangzhou Baiyunshan Pharmaceutical Holdings Company (GU5) Financial Statements
Guangzhou Baiyunshan Pharmaceutical Holdings Company Financial Overview
Guangzhou Baiyunshan Pharmaceutical Holdings Company's market cap is currently $4.02B. The company's EPS TTM is $1.33; its P/E ratio is 14.74; and it has a dividend yield of 4.80%. Guangzhou Baiyunshan Pharmaceutical Holdings Company has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 77.66B | $ 74.99B | $ 75.52B | $ 70.79B | $ 69.01B |
| Gross Profit | $ 12.52B | $ 12.52B | $ 14.19B | $ 13.28B | $ 13.23B |
| Operating Income | $ 3.63B | $ 3.60B | $ 5.12B | $ 5.07B | $ 4.79B |
| EBITDA | $ 3.95B | $ 4.90B | $ 6.49B | $ 6.22B | $ 5.82B |
| Net Income | $ 2.98B | $ 2.84B | $ 4.06B | $ 3.97B | $ 3.72B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 23.81B | $ 22.72B | $ 21.31B | $ 22.56B | $ 22.38B |
| Total Assets | $ 84.55B | $ 81.68B | $ 78.59B | $ 74.67B | $ 66.12B |
| Total Debt | $ 20.70B | $ 12.37B | $ 11.70B | $ 11.43B | $ 9.92B |
| Net Debt | $ 5.75B | $ -5.90B | $ -9.61B | $ -11.07B | $ -12.45B |
| Total Liabilities | $ 43.40B | $ 43.91B | $ 41.91B | $ 41.03B | $ 34.79B |
| Stockholders' Equity | $ 37.80B | $ 35.90B | $ 34.92B | $ 32.07B | $ 29.06B |
| Cash Flow | |||||
| Free Cash Flow | $ -954.34M | $ 2.31B | $ 2.48B | $ 5.62B | $ 4.42B |
| Operating Cash Flow | $ 253.50M | $ 3.44B | $ 4.10B | $ 7.00B | $ 5.67B |
| Investing Cash Flow | $ -3.81B | $ -5.96B | $ -3.11B | $ -7.25B | $ -931.57M |
| Financing Cash Flow | $ -98.13M | $ -1.01B | $ -1.98B | $ 45.95M | $ -1.49B |
Currency in CNY